SCHEMBL20168171

SCHEMBL20168171

Nc1nc(I)nc2[nH]ccc12

nearest known ligand 0.46

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
DYRK1A Q13627 1/20 0.46
HRH4 Q9H3N8 2/20 0.38
ADORA2A P29274 2/20 0.38
ADORA1 P30542 2/20 0.38
IKBKB O14920 1/20 0.37
CHUK O15111 1/20 0.37
TTBK1 Q5TCY1 3/20 0.33
TTBK2 Q6IQ55 3/20 0.33
PRKCI P41743 2/20 0.33
AXL P30530 2/20 0.33
TTK P33981 1/20 0.33
JAK2 O60674 1/20 0.33
MAPK1 P28482 1/20 0.32
PIK3R1 P27986 1/20 0.32
PIK3CA P42336 1/20 0.32
JAK3 P52333 1/20 0.32
NUDT1 P36639 1/20 0.31
DHFR P00374 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1057965 0.79 HRH4 (0.51) DYRK1AHRH4ADORA2AADORA1IKBKB
Hydrochloric Acid SCHEMBL28275524 0.78 HRH4 (0.50) DYRK1AHRH4ADORA2AADORA1IKBKB
SCHEMBL1016847 0.76 DYRK1A (0.46) DYRK1AHRH4ADORA2AADORA1IKBKB
SCHEMBL1689372 0.76 DYRK1A (0.46) DYRK1AHRH4ADORA2AADORA1IKBKB
SCHEMBL13666508 0.76 PRKCI (0.41) DYRK1AHRH4ADORA2AADORA1IKBKB
SCHEMBL29981526 0.76 DYRK1A (0.46) DYRK1AHRH4ADORA2AADORA1IKBKB
SCHEMBL18055932 0.76 DYRK1A (0.46) DYRK1AHRH4ADORA2AADORA1IKBKB
Hydrochloric Acid SCHEMBL29616498 0.74 DYRK1A (0.44) DYRK1AHRH4ADORA2AADORA1IKBKB
Hydrochloric Acid SCHEMBL29616579 0.74 DYRK1A (0.44) DYRK1AHRH4ADORA2AADORA1IKBKB
SCHEMBL12574791 0.73 DYRK1A (0.43) DYRK1AHRH4ADORA2AADORA1IKBKB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2022260336-A2 NUCLEOSIDE DERIVATIVE HAVING MULTI-TARGET KINASE INHIBITORY ACTIVITY AND PHARMACEUTICAL COMPOSITION FOR PREVENTING AND TREATING CANCER COMPRISING SAME 퓨쳐메디신 주식회사 2022-12-15 WO disclosed
EP-3541390-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS Cystic Fibrosis Foundation Therapeutics Inc. (US) 2019-09-25 EP disclosed
WO-2018094137-A1 PYRROLOPYRIMIDINES AS CFTR POTENTIATORS CYSTIC FIBROSIS FOUNDATION THERAPEUTICS INC. (US) 2018-05-24 WO disclosed